Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Half-year Report

23 Sep 2025 07:00

RNS Number : 3367A
Primorus Investments PLC
23 September 2025
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Interim Results for the six months ended 30 June 2025

 

Primorus Investments plc (AIM: PRIM) is pleased to announce its unaudited interim results for the six months ended 30 June 2025.

 

Overview

Following a year of exceptional performance in 2024, the first half of 2025 has seen more measured activity, with only one exit in the period. Nevertheless, the portfolio continues to progress strongly, particularly Fresho. With a solid cash position and a healthy pipeline of opportunities, we remain confident in our ability to generate attractive returns for shareholders.

 

Fresho continues to expand its platform, reporting strong user growth and revenue momentum.

 

After reaching profitability in late 2024, VirtualStock's volume and order growth has continued to strengthen with Asda and Homebase now using Virtualstock's dropship technology.

 

Interpac completed a significant funding round which has left the company well capitalised and in a strong financial position to strengthen the existing management team as well as fund future production and sales. Primorus joined the funding round, investing a further £275,000, and now holds 4.3% of the issued share capital on a fully diluted basis.

 

Priority Intelligence Group plc - Primorus disposed of its shareholding in June this year for gross proceeds of £977,000.

 

At the Annual General Meeting, Primorus proposed a share buyback programme which was subject to shareholder approval of a rule 9 waiver agreed by the Takeover Panel. This resolution was passed by the independent shareholders and, as at the date of these financial statements, the Company has purchased 12,566,388 shares.

 

Financial Results

The operating loss for the six months to 30 June 2025 was £606,000 (30 June 2024: £2,764,000 profit). The net loss after tax was £606,000 (30 June 2024: £2,764,000 profit).

 

Total assets, including cash, at 30 June 2025 amounted to £5.30 million (30 June 2024: £5.98 million).

 

Outlook

The Board expects continued resilience across the portfolio in the second half of 2025, with the hope of further realisations over the short to medium term. While global macroeconomic conditions remain uncertain, Primorus is positioned to deliver long-term shareholder value through disciplined deployment and active portfolio management. We will seek to return capital to shareholders when the opportunities arise.

 

We look forward to updating shareholders as and when our existing investments mature, and new investments present themselves.

 

The Directors would like to take this opportunity to thank our shareholders for their continued support.

 

Rupert Labrum Chairman

22nd September 2025

 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson / James Western

 

+44 (0) 20 7213 0880

 

 

 

 

Unaudited Condensed Company Statement of Comprehensive Income

for the six months ended 30 June 2025

 

6 months to

6 months to

Year to

30 June

2025

30 June

2024

31 December

2024

Unaudited

Unaudited

Unaudited

Notes

£'000

£'000

£'000

Continuing operations

Income

Realised (loss)/gain on financial investments

(332)

3,206

3,168

Unrealised (loss)/gain on financial investments

(19)

(42)

233

Other income

19

-

-

Gross (Loss)/profit

(332)

3,164

3,401

 

Operating expenses

Administrative expenses

(274)

(417)

(720)

Operating (Loss)/profit

(606)

2,747

(2,681)

Finance income

-

17

17

Finance costs

-

-

(9)

(Loss)/profit before tax

(606)

2,764

2,689

Taxation

-

-

-

(Loss)/profit for the period

(606)

2,764

2,689

Other comprehensive income for the period net of tax

-

-

-

Total Comprehensive Income

(606)

2,764

2,689

 

(Loss)/profit per share:

Basic (loss)/profit per share (pence)

3

(0.433)

1.977

1.923

Diluted (loss)/profit per share (pence)

3

(0.433)

1.977

1.923

 

 

Unaudited Condensed Company Statement of Financial Position

as at 30 June 2025

 

30 June

2025

30 June

2024

31 December

2024

Unaudited

Unaudited

Audited

Note s

£'000

£'000

£'000

ASSETS

Non-current assets

Financial investments

3,633

2,941

4,733

3,633

2,941

4,733

 

Current assets

Financial investments

649

2,925

1,054

Trade and other receivables

68

15

101

Cash and cash equivalents

956

95

42

1,673

3,035

1,197

Total assets

5,306

5,976

5,930

 

EQUITY

Equity attributable to equity holders of the parent

Share capital

280

280

280

Retained earnings

4,902

5,584

5,508

Total equity

5,182

5,864

5,788

LIABILITIES

Current liabilities

Trade and other payables

124

112

142

Corporation tax

-

-

-

Total liabilities

124

112

142

Total equity and liabilities

5,306

5,976

5,930

Unaudited Condensed Company Statement of Changes in Equity

for the six months ended 30 June 2025

 

 

Share capital

 

Retained earnings

Total attributable to owners of parent

Unaudited

£'000

£'000

£'000

 

 

 

 

Balance at 31 December 2023

 

280

 

4,917

 

5,197

 

Profit for the period

 

-

 

2,689

 

2,689

 

Total comprehensive income for the period

 

-

 

2,689

 

2,689

 

Dividend paid during the period

 

-

 

(2,098)

 

(2,098)

Balance at 31 December 2024

280

5,508

5,788

 

Loss for the period

 

-

 

(606)

 

(606)

 

Total comprehensive income for the period

 

-

 

(606)

 

(606)

Balance at 30 June 2025

280

4,902

5,182

 

 

 

Unaudited Condensed Company Statement of Cash Flows

for the six months ended 30 June 2025

 

 

6 months to

6 months to

Year to

30 Jun 25

30 Jun 24

31 Dec 24

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash Flows from Operating Activities

Operating (loss)/profit before tax

(606)

2,764

2,681

Adjustments for:

Loss/(profit) on disposal of financial investments

332

(3,206)

(3,168)

Fair value movements on financial investments

19

42

(233)

Net foreign exchange loss

61

59

163

(194)

(341)

(557)

Movement in working capital:

Decrease/(increase) in trade and other receivables

33

(3)

(89)

(Decrease)/increase in trade and other payables

(18)

(32)

(2)

Cash used in operations

(179)

(376)

(648)

Income taxes paid

-

-

-

Net cash used in operating activities

(179)

(376)

(648)

Cash flows from investing activities

Proceeds from sale of financial investments

1,368

4,789

6,121

Purchase of financial investments

(275)

(2,995)

(4,116)

Net cash from investing activities

1,093

1,794

2,005

 

Dividends paid

-

(2,098)

(2,098)

Finance income

17

Finance cost

(9)

Cash flow from financing activities

-

(2,098)

(2,090)

 

Net change in cash and cash equivalents

914

(680)

(733)

 

Cash and cash equivalents at beginning of period

 

42

 

775

 

775

Cash and cash equivalents at end of period

956

95

42

 

 

Notes to the condensed unaudited interim financial statements

 

1. General Information

 

The condensed interim financial information for the 6 months to 30 June 2025 does not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006 and has not been audited or reviewed. No statutory accounts for the period have been delivered to the Registrar of Companies.

 

The condensed interim financial information in respect of the year ended 31 December 2024 has been produced using extracts from the statutory accounts for that period. Consequently, this does not constitute the statutory information (as defined in section 434 of the Companies Act 2006) for the year ended 31 December 2024, which was audited. The statutory accounts for this period have been filed with the Registrar of Companies. The auditors' report was unqualified and did not contain a statement under Sections 498 (2) or 498 (3) of the Companies Act 2006.

 

The auditor's report was approved by the Directors on 29 May 2025 and is available on the Company's website at www.primorusinvestments.com.

 

2. Basis of preparation and accounting

 

The financial information has been prepared on the historical cost basis. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Chairman's Statement. This statement also includes a summary of the Company's financial position and its cash flows.

 

The financial statements have been prepared in accordance with the Companies Act 2006 and UK-adopted international accounting standards (UK-adopted IAS) and related interpretations. As permitted, this does not include IAS 34 "Interim Financial Reporting". This condensed set of financial statements has been prepared applying the accounting policies that were applied in the preparation of the Company's published financial statements for the year ended 31 December 2024. As these interim financial statements do not include all the information or disclosures required in the annual financial statements they should be read in conjunction with the Company's 2024 annual financial statements.

 

3. Earnings per share

 

Earnings per ordinary share has been calculated using the weighted average number of shares in issue during the period. The weighted average number of equity shares in issue was 139,830,968. IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease earnings per share or increase the loss per share.

 

6 months to

6 months to

Year ended

30 June

2025

30 June

2024

31 December

2024

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

Net (loss)/profit attributable to equity holders of

  the company

(606)

2,764

2,689

Weighted average number of shares

139,830,968

139,830,968

139,830,968

Weighted average number of diluted shares

139,830,968

139,830,968

139,830,968

Basic profit/(loss) per share (pence)

(0.433)

1.977

1.923

Diluted profit/(loss) per share (pence)

(0.433)

1.977

1.923

 

 

4. Events after the reporting date

 

There are no events after the end of the reporting date to disclose that have not already been the subject of an announcement by the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDCXUDDGUD
Date   Source Headline
25th Jan 20127:00 amRNSRenewal of License
30th Dec 20117:00 amRNSTotal Voting Rights
16th Dec 201111:57 amRNSDirector Resignation
2nd Dec 20117:00 amRNSAcquisition
23rd Nov 20111:34 pmRNSChange of Registered Office
23rd Nov 201111:30 amRNSResult of Meeting
15th Nov 201112:10 pmRNSRevised placing
8th Nov 20117:00 amRNSProposed adoption of investing policy
4th Nov 20111:40 pmRNSIssue of equity and Board changes
30th Sep 20117:00 amRNSHalf Yearly Report
17th Aug 20118:35 amRNSLitigation Settlement
26th Jul 201110:18 amRNSResult of AGM
20th Jul 201110:14 amRNSChange of Registered Office - Replacement
20th Jul 20119:49 amRNSChange of Registered Office
5th Jul 20118:40 amRNSHolding(s) in Company
30th Jun 20112:44 pmRNSAnnual Report & Accounts and AGM Notice
30th Jun 20112:08 pmRNSFinal Results
15th Mar 201110:50 amRNSResult of Meeting
18th Feb 20112:00 pmRNSCircular re proposed Investing Policy
13th Jan 20111:17 pmRNSDistribution from associated company
11th Jan 20119:31 amRNSDirector/PDMR Shareholding
17th Dec 20108:36 amRNSCessation of business
3rd Nov 20107:00 amRNSNominated adviser and broker change of name
30th Sep 20107:00 amRNSHalf Yearly Report
24th Aug 20102:59 pmRNSHolding(s) in Company
30th Jun 201010:14 amRNSResult of AGM
8th Jun 201011:46 amRNSNotice of AGM
28th May 20107:00 amRNSLitigation Claim
12th May 20107:00 amRNSAnnual Report & Accounts
31st Mar 20107:00 amRNSFinal Results
11th Feb 20107:00 amRNSTrading Update
9th Dec 20097:00 amRNSDirectorate Change
1st Dec 20092:57 pmRNSDirector/PDMR Shareholding
19th Oct 20094:46 pmRNSDirector/PDMR Shareholding
30th Sep 20097:00 amRNSHalf Yearly Report
21st Sep 20092:09 pmRNSChange of Adviser
22nd Jul 20091:36 pmRNSResult of AGM
14th May 20092:06 pmRNSHolding(s) in Company
20th Apr 20099:04 amRNSDirector/PDMR Shareholding
17th Apr 20097:00 amRNSStmnt re Share Price Movement
31st Mar 20092:03 pmRNSPreliminary Results
17th Feb 20094:55 pmRNSHolding(s) in Company
5th Feb 20097:00 amRNSHolding in Company
31st Oct 20084:17 pmRNSDirectorate Change
31st Oct 20084:14 pmRNSChange of Registered Office
24th Oct 200810:29 amRNSResult of General Meeting
3rd Oct 20083:21 pmRNSCirc re. Disposal of Icon
3rd Oct 20089:39 amRNSDisposal of Icon Display
3rd Oct 20089:36 amRNSChange of Adviser
30th Sep 20083:27 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.